Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 in relapsed SCLC with MYC or CDKN2A/TP53 mutations
NCT02688907Phase 2Terminated
- Sponsor
- Samsung Medical Center
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in small cell lung cancer (SCLC), sponsored by Samsung Medical Center. Started Jun 2016; status: terminated.
02
Drugs
adavosertib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02688907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688907.